Irritable bowel syndrome. Irritable bowel syndrome without diarrhea
Conditions
Interventions
Intervention 1: Intervention group: P.atlantica oleoresin capsule (Saqez) and placebo are prepared by a pharmacist in the traditional pharmacy laboratory of the Faculty of Traditional Medicine of Babo
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient has not been treated with Pistacia atlantica oleoresin for the past month Patients with IBS whose type of disease has been confirmed by a complete medical examination. The patient signs a written consent Age over 18 years
Exclusion criteria
Exclusion criteria: Pregnant or lactating women Patients with malignancies or other chronic gastrointestinal diseases such as inflammatory bowel disease and celiac disease History of major gastrointestinal surgery (including Billroth surgery, ostomy, and any resection in any part of the gastrointestinal tract). Inability to swallow capsules People taking psychotherapy drugs Patients at a serious health risk, including severe heart, liver or kidney disease Patients with severe plant allergies Regular use of drugs that change the movement of the gastrointestinal tract such as metoclopramide, cisapride, drugs, diphenoxylate, etc. Regular use of laxatives Follow the diet plans with daily and regular intake of prebiotic/probiotic compounds Taking antibiotics The patient has been treated with Pistacia atlantica for the past month Cigarette smoking, alcohol usage NSAID usage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the severity of irritable bowel syndrome based on the total score of the IBS-SSS scale. Timepoint: The beginning of the study and the sixth week of the intervention and one month after the intervention. Method of measurement: Irritable Bowel Syndrome Severity Questionnaire (IBS-SSS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life based on change in total score of IBS-QOL quality of life questionnaire, change in symptoms of IBS-SSS Irritable Bowel Syndrome Scale. Timepoint: Initially study and the sixth week of intervention and one month after intervention. Method of measurement: Quality of Life Questionnaire for Patients with Irritable Bowel Syndrome (IBS-QOL).;The severity of symptoms subsets of the IBS-SSS Irritable Bowel Syndrome questionnaire. Timepoint: Initially study and the sixth week of intervention and one month after intervention. Method of measurement: IBS-SSS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Adibifard
Babol University of Medical Sciences
Outcome results
None listed